Amneal Agrees to Acquire Kashiv BioSciences to Create Global Biosimilar Leader; Reports Strong Preliminary First Quarter 2026 Financial Results and Raises FY2026 Standalone Guidance
Go back to Amneal Agrees to Acquire Kashiv BioSciences to Create Global Biosimilar Leader; Reports Strong Preliminary First Quarter 2026 Financial Results and Raises FY2026 Standalone Guidance| AmerElite Solutions, Inc. New (NASDAQ: AMRX) | Delayed: 16.11 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $16.11 | 52 Week High | $0.19 | |||
| Open | $16.11 | 52 Week Low | $0.07 | |||
| Day High | $16.11 | P/E | N/A | |||
| Day Low | $16.11 | EPS | $-0.01 | |||
| Volume | 132 | |||||
